📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
30
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌩️
Severe
Multiple high-probability dilution events detected
63%
💰 Capital Raise
93%
• Critical: only 1.1 months cash remaining
• Active shelf registration ($12M, 9% of market cap)
🔄 Reverse Split
45%
• 50-day avg $1.21 approaching $1 threshold
• Only 1 months cash — financial pressure
🔁 Convertible Conversion
15%
• Convertible debt present: 10.6% potential dilution
💹 Market Data
Market Cap$124.49M
Shares Outstanding100.40M
Float80.29M
Cash$4.16M
Debt$90.02M
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 5.76M shares
#1
Vanguard Group Inc
2.79M shares
#2
Geode Capital Management, LLC
552.4K shares
#3
Blackrock Inc.
415.8K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest11.60M
Days to Cover2.5
% of Float14.4%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
424B5
ATM
Apr 21, 2026
4
INSIDER TRANSACTION
Apr 17, 2026
4
INSIDER TRANSACTION
Apr 17, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for SRFM
📊 SRFM FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 SRFM Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.